Skip to main content

CLASS ACTION UPDATE for BIDU, SRNE and CLNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / June 3, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

BIDU Shareholders Click Here: https://www.zlk.com/pslra-1/baidu-inc-information-request-form?prid=7114&wire=1
SRNE Shareholders Click Here: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=7114&wire=1
CLNY Shareholders Click Here: https://www.zlk.com/pslra-1/colony-capital-inc-loss-submission-form?prid=7114&wire=1

* ADDITIONAL INFORMATION BELOW *

Baidu, Inc. (NASDAQ:BIDU)

BIDU Lawsuit on behalf of: investors who purchased March 16, 2019 - April 7, 2020
Lead Plaintiff Deadline : June 22, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/baidu-inc-information-request-form?prid=7114&wire=1

According to the filed complaint, during the class period, Baidu, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Baidu's feed services were not in compliance with applicable Chinese regulatory standards; (ii) the foregoing noncompliance subjected the Company to a heightened risk of regulatory enforcement, including the removal or suspension of certain of Baidu's services and products; (iii) accordingly, the Company's revenues derived from online marketing services were unlikely to be sustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)

SRNE Lawsuit on behalf of: investors who purchased May 15, 2020 - May 20, 2020
Lead Plaintiff Deadline : July 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=7114&wire=1

According to the filed complaint, during the class period, Sorrento Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Colony Capital, Inc. (NYSE:CLNY)

CLNY Lawsuit on behalf of: investors who purchased August 9, 2019 - May 7, 2020
Lead Plaintiff Deadline : July 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/colony-capital-inc-loss-submission-form?prid=7114&wire=1

According to the filed complaint, during the class period, Colony Capital, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Colony's sale of its industrial real estate portfolio and the bifurcation of Colony Credit Real Estate's portfolio were foreseeably likely to negatively impact Colony's financial and operating results; (ii) certain of Colony's remaining portfolio companies carried unsustainable levels of debt secured by hotels and healthcare-related properties and were thus at a significant risk of default; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/592629/CLASS-ACTION-UPDATE-for-BIDU-SRNE-and-CLNY-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.